Prognostic value of computed tomography scan detection of cartilage invasion in advanced laryngeal cancer treated with primary total laryngectomy.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
10 2022
Historique:
revised: 19 05 2022
received: 25 01 2022
accepted: 16 06 2022
pubmed: 9 7 2022
medline: 9 9 2022
entrez: 8 7 2022
Statut: ppublish

Résumé

We sought to determine whether detection of cartilage invasion (CI) by computed tomography predicts oncologic outcomes after primary total laryngectomy. Retrospective cohort study comparing oncologic outcomes between radiologic versus pathologic diagnosis. Assessment of clear CI versus gestalt CI resulted in 84% versus 48% specificity, 90.9% versus 80.3% positive predictive value (PPV), 60.6% versus 80.3% sensitivity, 44.7% versus 48% negative predictive value (NPV), respectively. Disease-free survival (DFS) was similar between cT4a and cT3/cT2 patients (p = 0.87). DFS trended towards superiority among pT3/pT2 versus pT4a patients (p = 0.18). DFS was similar among patients with CI on radiologist gestalt versus no CI (p = 0.94). Histologically confirmed CI was associated with a hazard ratio (HR) of 1.46 (p = 0.27), gestalt CI 1.13 (p = 0.70), and clear CI 1.61 (p = 0.10) for DFS. Gestalt determination of CI results in high sensitivity but low specificity, while clear determination of CI results in moderate sensitivity and high specificity.

Sections du résumé

BACKGROUND
We sought to determine whether detection of cartilage invasion (CI) by computed tomography predicts oncologic outcomes after primary total laryngectomy.
METHODS
Retrospective cohort study comparing oncologic outcomes between radiologic versus pathologic diagnosis.
RESULTS
Assessment of clear CI versus gestalt CI resulted in 84% versus 48% specificity, 90.9% versus 80.3% positive predictive value (PPV), 60.6% versus 80.3% sensitivity, 44.7% versus 48% negative predictive value (NPV), respectively. Disease-free survival (DFS) was similar between cT4a and cT3/cT2 patients (p = 0.87). DFS trended towards superiority among pT3/pT2 versus pT4a patients (p = 0.18). DFS was similar among patients with CI on radiologist gestalt versus no CI (p = 0.94). Histologically confirmed CI was associated with a hazard ratio (HR) of 1.46 (p = 0.27), gestalt CI 1.13 (p = 0.70), and clear CI 1.61 (p = 0.10) for DFS.
CONCLUSION
Gestalt determination of CI results in high sensitivity but low specificity, while clear determination of CI results in moderate sensitivity and high specificity.

Identifiants

pubmed: 35801556
doi: 10.1002/hed.27133
pmc: PMC9544100
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2220-2227

Informations de copyright

© 2022 The Authors. Head & Neck published by Wiley Periodicals LLC.

Références

Eur J Radiol. 2000 Mar;33(3):216-29
pubmed: 10699738
Eur Radiol. 2020 Jul;30(7):3803-3812
pubmed: 32152744
Head Neck. 2022 Oct;44(10):2220-2227
pubmed: 35801556
Oral Oncol. 2019 Jan;88:137-144
pubmed: 30616784
Radiology. 1974 Jun;111(3):697-700
pubmed: 4829005
Int J Radiat Oncol Biol Phys. 1990 Aug;19(2):485-90
pubmed: 2394626
Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1011-21
pubmed: 9169807
J Clin Oncol. 2010 May 10;28(14):2318-22
pubmed: 20368569
Radiology. 1995 Sep;196(3):735-9
pubmed: 7644637
Head Neck. 2019 Jan;41(1):72-78
pubmed: 30536660
AJNR Am J Neuroradiol. 1998 Apr;19(4):719-22
pubmed: 9576661
Eur Arch Otorhinolaryngol. 2013 Jan;270(1):287-91
pubmed: 22460527
Laryngoscope. 2015 Jul;125(7):1650-5
pubmed: 26307809
Otolaryngol Head Neck Surg. 2007 Feb;136(2):291-5
pubmed: 17275557
J Clin Oncol. 2018 Apr 10;36(11):1143-1169
pubmed: 29172863
Head Neck. 2016 Aug;38(8):1271-7
pubmed: 27043228
Auris Nasus Larynx. 2017 Jun;44(3):333-339
pubmed: 27569289

Auteurs

Maxwell Y Lee (MY)

Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio, USA.

Jonathan Lee (J)

Department of Diagnostic Radiology, Cleveland Clinic, Cleveland, Ohio, USA.

Sarah Stock (S)

Department of Diagnostic Radiology, Cleveland Clinic, Cleveland, Ohio, USA.

Mario Belfiglio (M)

Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio, USA.

Brian Matia (B)

Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA.

Shlomo Koyfman (S)

Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.

Nikhil P Joshi (NP)

Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois, USA.

Brian B Burkey (BB)

Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA.

Eric Lamarre (E)

Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA.

Brandon Prendes (B)

Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA.

Joseph Scharpf (J)

Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA.

Robert R Lorenz (RR)

Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA.

Neil M Woody (NM)

Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.

David J Adelstein (DJ)

Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.

Jessica L Geiger (JL)

Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.

Deborah J Chute (DJ)

Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA.

Jamie A Ku (JA)

Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH